Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension

Raymond R. Townsend, O. Bryan Holland

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

In recent years there has been increased discussion about goals of antihypertensive therapy other than blood pressure reduction. The development of angiotensin-converting enzyme inhibitors has provided a class of drugs with a very low side-effect profile. However, single-drug therapy is effective in only about half of hypertensive patients. In the past, diuretics have traditionally been used as the initial or second antihypertensive. Increasingly, diuretic therapy is being avoided, and other antihypertensive combinations are being used. In controlled trials, combination converting enzyme inhibitor-diuretic therapy is effective in about 85% of patients. This synergistic combination allows the diuretic dose to be reduced so that the adverse effects and metabolic complications are minimized. At this time, the combination of converting enzyme inhibitor and diuretic provides an ideal choice in terms of efficacy, compliance, side effects, and cost.

Original languageEnglish (US)
Pages (from-to)1175-1183
Number of pages9
JournalArchives of Internal Medicine
Volume150
Issue number6
StatePublished - Jun 1990

Fingerprint

Enzyme Inhibitors
Diuretics
Hypertension
Antihypertensive Agents
Therapeutics
Angiotensin-Converting Enzyme Inhibitors
Compliance
Blood Pressure
Costs and Cost Analysis
Drug Therapy
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension. / Townsend, Raymond R.; Holland, O. Bryan.

In: Archives of Internal Medicine, Vol. 150, No. 6, 06.1990, p. 1175-1183.

Research output: Contribution to journalArticle

Townsend, Raymond R. ; Holland, O. Bryan. / Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension. In: Archives of Internal Medicine. 1990 ; Vol. 150, No. 6. pp. 1175-1183.
@article{dd2ab3455103455aac65fc1c5f0a0d4a,
title = "Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension",
abstract = "In recent years there has been increased discussion about goals of antihypertensive therapy other than blood pressure reduction. The development of angiotensin-converting enzyme inhibitors has provided a class of drugs with a very low side-effect profile. However, single-drug therapy is effective in only about half of hypertensive patients. In the past, diuretics have traditionally been used as the initial or second antihypertensive. Increasingly, diuretic therapy is being avoided, and other antihypertensive combinations are being used. In controlled trials, combination converting enzyme inhibitor-diuretic therapy is effective in about 85{\%} of patients. This synergistic combination allows the diuretic dose to be reduced so that the adverse effects and metabolic complications are minimized. At this time, the combination of converting enzyme inhibitor and diuretic provides an ideal choice in terms of efficacy, compliance, side effects, and cost.",
author = "Townsend, {Raymond R.} and Holland, {O. Bryan}",
year = "1990",
month = "6",
language = "English (US)",
volume = "150",
pages = "1175--1183",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension

AU - Townsend, Raymond R.

AU - Holland, O. Bryan

PY - 1990/6

Y1 - 1990/6

N2 - In recent years there has been increased discussion about goals of antihypertensive therapy other than blood pressure reduction. The development of angiotensin-converting enzyme inhibitors has provided a class of drugs with a very low side-effect profile. However, single-drug therapy is effective in only about half of hypertensive patients. In the past, diuretics have traditionally been used as the initial or second antihypertensive. Increasingly, diuretic therapy is being avoided, and other antihypertensive combinations are being used. In controlled trials, combination converting enzyme inhibitor-diuretic therapy is effective in about 85% of patients. This synergistic combination allows the diuretic dose to be reduced so that the adverse effects and metabolic complications are minimized. At this time, the combination of converting enzyme inhibitor and diuretic provides an ideal choice in terms of efficacy, compliance, side effects, and cost.

AB - In recent years there has been increased discussion about goals of antihypertensive therapy other than blood pressure reduction. The development of angiotensin-converting enzyme inhibitors has provided a class of drugs with a very low side-effect profile. However, single-drug therapy is effective in only about half of hypertensive patients. In the past, diuretics have traditionally been used as the initial or second antihypertensive. Increasingly, diuretic therapy is being avoided, and other antihypertensive combinations are being used. In controlled trials, combination converting enzyme inhibitor-diuretic therapy is effective in about 85% of patients. This synergistic combination allows the diuretic dose to be reduced so that the adverse effects and metabolic complications are minimized. At this time, the combination of converting enzyme inhibitor and diuretic provides an ideal choice in terms of efficacy, compliance, side effects, and cost.

UR - http://www.scopus.com/inward/record.url?scp=0025353862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025353862&partnerID=8YFLogxK

M3 - Article

C2 - 2191634

AN - SCOPUS:0025353862

VL - 150

SP - 1175

EP - 1183

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 6

ER -